Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 48
Results: 6
Targeting cell cycle and hormone receptor pathways in cancer.
- Published in:
- Oncogene, 2013, v. 32, n. 48, p. 5481, doi. 10.1038/onc.2013.83
- By:
- Publication type:
- Article
HOX-mediated LMO2 expression in embryonic mesoderm is recapitulated in acute leukaemias.
- Published in:
- Oncogene, 2013, v. 32, n. 48, p. 5471, doi. 10.1038/onc.2013.175
- By:
- Publication type:
- Article
siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/− with susceptibility versus C57BL/6-Trp53+/− mice with resistance to mammary tumors.
- Published in:
- Oncogene, 2013, v. 32, n. 48, p. 5458, doi. 10.1038/onc.2013.38
- By:
- Publication type:
- Article
Human antibodies targeting the C-type lectin-like domain of the tumor endothelial cell marker clec14a regulate angiogenic properties in vitro.
- Published in:
- Oncogene, 2013, v. 32, n. 48, p. 5449, doi. 10.1038/onc.2013.156
- By:
- Publication type:
- Article
Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B.
- Published in:
- Oncogene, 2013, v. 32, n. 48, p. 5439, doi. 10.1038/onc.2013.99
- By:
- Publication type:
- Article
SATB1 collaborates with loss of p16 in cellular transformation.
- Published in:
- Oncogene, 2013, v. 32, n. 48, p. 5492, doi. 10.1038/onc.2013.158
- By:
- Publication type:
- Article